Free Trial

Trellus Health (TRLS) Competitors

GBX 1.86 0.00 (0.00%)
As of 06:12 AM Eastern

TRLS vs. FDBK, INHC, IQAI, DVRG, SENS, EMIS, CRW, INS, KOO, and RENX

Should you be buying Trellus Health stock or one of its competitors? The main competitors of Trellus Health include Feedback (FDBK), Induction Healthcare Group (INHC), IQ-AI (IQAI), DeepVerge (DVRG), Sensyne Health (SENS), EMIS Group (EMIS), Craneware (CRW), Instem (INS), Kooth (KOO), and Renalytix (RENX). These companies are all part of the "health information services" industry.

Trellus Health vs.

Trellus Health (LON:TRLS) and Feedback (LON:FDBK) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, community ranking, dividends, risk, media sentiment, valuation, earnings, profitability and institutional ownership.

Trellus Health has a beta of 0.01, indicating that its stock price is 99% less volatile than the S&P 500. Comparatively, Feedback has a beta of 0.77, indicating that its stock price is 23% less volatile than the S&P 500.

Trellus Health has higher earnings, but lower revenue than Feedback. Feedback is trading at a lower price-to-earnings ratio than Trellus Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Trellus Health£65.83K54.77-£7.98M-£3.45-0.54
Feedback£3.88M1.96-£10.84M-£24.74-0.70

Feedback received 165 more outperform votes than Trellus Health when rated by MarketBeat users.

CompanyUnderperformOutperform
Trellus HealthN/AN/A
FeedbackOutperform Votes
165
67.07%
Underperform Votes
81
32.93%

In the previous week, Trellus Health's average media sentiment score of 0.00 equaled Feedback'saverage media sentiment score.

Company Overall Sentiment
Trellus Health Neutral
Feedback Neutral

Feedback has a net margin of -279.16% compared to Trellus Health's net margin of -12,114.55%. Trellus Health's return on equity of -37.95% beat Feedback's return on equity.

Company Net Margins Return on Equity Return on Assets
Trellus Health-12,114.55% -37.95% -22.76%
Feedback -279.16%-39.71%-22.99%

19.3% of Trellus Health shares are held by institutional investors. Comparatively, 53.2% of Feedback shares are held by institutional investors. 49.7% of Trellus Health shares are held by company insiders. Comparatively, 10.8% of Feedback shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

Trellus Health beats Feedback on 7 of the 12 factors compared between the two stocks.

Remove Ads
Get Trellus Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for TRLS and its competitors with MarketBeat's FREE daily newsletter.

TRLS vs. The Competition

MetricTrellus HealthHealth Information Services IndustryMedical SectorLON Exchange
Market Cap£3.61M£211.52M£5.67B£2.61B
Dividend YieldN/A6.68%4.40%4.86%
P/E Ratio-0.54257.0523.90157.46
Price / Sales54.77485.02395.61304,182.74
Price / Cash0.7650.4338.1128.23
Price / Book0.195.116.834.54
Net Income-£7.98M-£16.71M£3.20B£5.80B
7 Day Performance-4.11%0.19%8.77%-0.09%
1 Month Performance-6.75%-8.85%-0.35%-4.17%
1 Year Performance-32.18%2.77%13.04%33.84%

Trellus Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TRLS
Trellus Health
N/AGBX 1.87
flat
N/A-32.2%£3.61M£65,831.01-0.5431Gap Down
FDBK
Feedback
N/AGBX 17.63
-0.7%
N/A-86.5%£7.72M£3.88M-0.7124
INHC
Induction Healthcare Group
N/AGBX 6.38
-5.6%
N/A-58.2%£5.88M£12.57M-1.1574
IQAI
IQ-AI
N/AGBX 1.34
-4.6%
N/A-21.2%£2.96M£538,190.00-13.676Gap Down
DVRG
DeepVerge
N/AN/AN/AN/A£1.14M£12.41M-15.0073
SENS
Sensyne Health
N/AN/AN/AN/A£583,000.00£7.81M-0.0270Gap Down
EMIS
EMIS Group
N/AN/AN/AN/A£1.23B£176.86M4,085.111,560
CRW
Craneware
2.1595 of 5 stars
GBX 1,794.75
-1.9%
GBX 2,700
+50.4%
-18.1%£771.14M£230.77M66.31734Gap Up
INS
Instem
N/AN/AN/AN/A£199.62M£61.63M5,928.57500
KOO
Kooth
2.7134 of 5 stars
GBX 154.20
+1.8%
GBX 583.33
+278.3%
-51.7%£56.60M£50.72M14.49478Analyst Forecast
RENX
Renalytix
N/AGBX 9.50
-7.3%
N/A-73.8%£39.38M£9.22M-0.45102
Remove Ads

Related Companies and Tools


This page (LON:TRLS) was last updated on 3/17/2025 by MarketBeat.com Staff
From Our Partners